135 related articles for article (PubMed ID: 18242992)
21. Imidazoquinoxaline Src-family kinase p56Lck inhibitors: SAR, QSAR, and the discovery of (S)-N-(2-chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5-a]pyrido[3,2-e]pyrazin-6-amine (BMS-279700) as a potent and orally active inhibitor with excellent in vivo antiinflammatory activity.
Chen P; Doweyko AM; Norris D; Gu HH; Spergel SH; Das J; Moquin RV; Lin J; Wityak J; Iwanowicz EJ; McIntyre KW; Shuster DJ; Behnia K; Chong S; de Fex H; Pang S; Pitt S; Shen DR; Thrall S; Stanley P; Kocy OR; Witmer MR; Kanner SB; Schieven GL; Barrish JC
J Med Chem; 2004 Aug; 47(18):4517-29. PubMed ID: 15317463
[TBL] [Abstract][Full Text] [Related]
22. Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo.
Smits RA; Lim HD; Hanzer A; Zuiderveld OP; Guaita E; Adami M; Coruzzi G; Leurs R; de Esch IJ
J Med Chem; 2008 Apr; 51(8):2457-67. PubMed ID: 18357976
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and PKCtheta inhibitory activity of a series of 4-indolylamino-5-phenyl-3-pyridinecarbonitriles.
Dushin RG; Nittoli T; Ingalls C; Boschelli DH; Cole DC; Wissner A; Lee J; Yang X; Morgan P; Brennan A; Chaudhary D
Bioorg Med Chem Lett; 2009 May; 19(9):2461-3. PubMed ID: 19345579
[TBL] [Abstract][Full Text] [Related]
24. Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists.
Cheng Y; Albrecht BK; Brown J; Buchanan JL; Buckner WH; DiMauro EF; Emkey R; Fremeau RT; Harmange JC; Hoffman BJ; Huang L; Huang M; Lee JH; Lin FF; Martin MW; Nguyen HQ; Patel VF; Tomlinson SA; White RD; Xia X; Hitchcock SA
J Med Chem; 2008 Aug; 51(16):5019-34. PubMed ID: 18680277
[TBL] [Abstract][Full Text] [Related]
25. 3-amino-7-phthalazinylbenzoisoxazoles as a novel class of potent, selective, and orally available inhibitors of p38alpha mitogen-activated protein kinase.
Pettus LH; Xu S; Cao GQ; Chakrabarti PP; Rzasa RM; Sham K; Wurz RP; Zhang D; Middleton S; Henkle B; Plant MH; Saris CJ; Sherman L; Wong LM; Powers DA; Tudor Y; Yu V; Lee MR; Syed R; Hsieh F; Tasker AS
J Med Chem; 2008 Oct; 51(20):6280-92. PubMed ID: 18817364
[TBL] [Abstract][Full Text] [Related]
26. Treatment with N-tosyl-l-phenylalanine chloromethyl ketone after the onset of collagen-induced arthritis reduces joint erosion and NF-kappaB activation.
Choi J; Ha KH; Byun MS; Min SY; Park MJ; Park HS; Oh HJ; Ju JH; Kim HY; Jue DM
Eur J Pharmacol; 2008 Oct; 595(1-3):108-13. PubMed ID: 18706406
[TBL] [Abstract][Full Text] [Related]
27. Discovery of an in vitro and in vivo potent resorcylic lactone analog of LL-Z1640-2 as anti-inflammatory lead, II.
Shen Y; Du H; Kotake M; Matsushima T; Goto M; Shirota H; Gusovsky F; Li X; Jiang Y; Schiller S; Spyvee M; Davis H; Zhang Z; Pelletier R; Ikemori-Kawada M; Kawakami Y; Inoue A; Wang Y
Bioorg Med Chem Lett; 2010 May; 20(10):3047-9. PubMed ID: 20427182
[TBL] [Abstract][Full Text] [Related]
28. Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats.
Conway JG; Pink H; Bergquist ML; Han B; Depee S; Tadepalli S; Lin P; Crumrine RC; Binz J; Clark RL; Selph JL; Stimpson SA; Hutchins JT; Chamberlain SD; Brodie TA
J Pharmacol Exp Ther; 2008 Jul; 326(1):41-50. PubMed ID: 18434589
[TBL] [Abstract][Full Text] [Related]
29. Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore.
Razavi H; Riether D; Harcken C; Bentzien J; Dinallo RM; Souza D; Nelson RM; Kukulka A; Fadra-Khan TN; Pack EJ; Zuvela-Jelaska L; Pelletier J; Panzenbeck M; Torcellini CA; Proudfoot JR; Nabozny GH; Thomson DS
Bioorg Med Chem Lett; 2014 Apr; 24(8):1934-40. PubMed ID: 24656565
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and anti-inflammatory activity of 3-(4'-geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid and its ester derivatives.
Epifano F; Genovese S; Sosa S; Tubaro A; Curini M
Bioorg Med Chem Lett; 2007 Oct; 17(20):5709-14. PubMed ID: 17768049
[TBL] [Abstract][Full Text] [Related]
31. Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis.
La DS; Belzile J; Bready JV; Coxon A; DeMelfi T; Doerr N; Estrada J; Flynn JC; Flynn SR; Graceffa RF; Harriman SP; Larrow JF; Long AM; Martin MW; Morrison MJ; Patel VF; Roveto PM; Wang L; Weiss MM; Whittington DA; Teffera Y; Zhao Z; Polverino AJ; Harmange JC
J Med Chem; 2008 Mar; 51(6):1695-705. PubMed ID: 18311900
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, biological evaluation, and enzyme docking simulations of 1,5-diarylpyrrole-3-alkoxyethyl ethers as selective cyclooxygenase-2 inhibitors endowed with anti-inflammatory and antinociceptive activity.
Anzini M; Rovini M; Cappelli A; Vomero S; Manetti F; Botta M; Sautebin L; Rossi A; Pergola C; Ghelardini C; Norcini M; Giordani A; Makovec F; Anzellotti P; Patrignani P; Biava M
J Med Chem; 2008 Aug; 51(15):4476-81. PubMed ID: 18598017
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in vitro evaluation of 2-amino-4-N-piperazinyl-6-(3,4-dimethoxyphenyl)-pteridines as dual immunosuppressive and anti-inflammatory agents.
De Jonghe S; Marchand A; Gao LJ; Calleja A; Cuveliers E; Sienaert I; Herman J; Clydesdale G; Sefrioui H; Lin Y; Pfleiderer W; Waer M; Herdewijn P
Bioorg Med Chem Lett; 2011 Jan; 21(1):145-9. PubMed ID: 21131199
[TBL] [Abstract][Full Text] [Related]
34. Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers.
Chauhan AS; Diwan PV; Jain NK; Tomalia DA
Biomacromolecules; 2009 May; 10(5):1195-202. PubMed ID: 19348417
[TBL] [Abstract][Full Text] [Related]
35. Novel synthesis and anti-inflammatory activities of 2,5-disubstituted-dioxacycloalkanes.
Bi L; Zhang Y; Zhao M; Wang C; Chan P; Tok JB; Peng S
Bioorg Med Chem; 2005 Oct; 13(19):5640-6. PubMed ID: 15996872
[TBL] [Abstract][Full Text] [Related]
36. Novel Class of Colony-Stimulating Factor 1 Receptor Kinase Inhibitors Based on an
Xie Z; Wu B; Liu Y; Ren W; Tong L; Xiang C; Wei A; Gao Y; Zeng L; Xie H; Tang W; Hu Y
J Med Chem; 2020 Feb; 63(3):1397-1414. PubMed ID: 31934767
[TBL] [Abstract][Full Text] [Related]
37. Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration.
Woodrow MD; Ballantine SP; Barker MD; Clarke BJ; Dawson J; Dean TW; Delves CJ; Evans B; Gough SL; Guntrip SB; Holman S; Holmes DS; Kranz M; Lindvaal MK; Lucas FS; Neu M; Ranshaw LE; Solanke YE; Somers DO; Ward P; Wiseman JO
Bioorg Med Chem Lett; 2009 Sep; 19(17):5261-5. PubMed ID: 19656678
[TBL] [Abstract][Full Text] [Related]
38. Colony-stimulating factor-1 receptor inhibitors for the treatment of cancer and inflammatory disease.
Patel S; Player MR
Curr Top Med Chem; 2009; 9(7):599-610. PubMed ID: 19689368
[TBL] [Abstract][Full Text] [Related]
39. Aminopyridinecarboxamide-based inhibitors: Structure-activity relationship.
Bonafoux DF; Bonar SL; Clare M; Donnelly AM; Glaenzer JL; Guzova JA; Huang H; Kishore NN; Koszyk FJ; Lennon PJ; Libby A; Mathialagan S; Oburn DS; Rouw SA; Sommers CD; Tripp CS; Vanella LJ; Weier R; Wolfson SG; Huang HC
Bioorg Med Chem; 2010 Jan; 18(1):403-14. PubMed ID: 19914076
[TBL] [Abstract][Full Text] [Related]
40. Discovery of novel analgesic and anti-inflammatory 3-arylamine-imidazo[1,2-a]pyridine symbiotic prototypes.
Lacerda RB; de Lima CK; da Silva LL; Romeiro NC; Miranda AL; Barreiro EJ; Fraga CA
Bioorg Med Chem; 2009 Jan; 17(1):74-84. PubMed ID: 19059783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
